Skip to main content
. 2021 Jun 29;12:653521. doi: 10.3389/fphar.2021.653521

FIGURE 4.

FIGURE 4

Global response rate and risk estimate between PD-1+ and PD-L1− for patients of ORR (A) and DCR (B). The ORR was 10.62% (95% CI, 4.67–16.56; I2, 78.80) vs. 3.07% (95% CI, 0.00–6.43; I2, 0.00) [RR, 2.935 (1.189, 7.244)]; the DCR was 17.95% (95% CI, 12.61–25.55; I2, 51.30) vs. 4.71% (95% CI, 1.81–12.25; I2, 00.00) [RR, 3.584 (1.337, 9.608)].